NattoPharma

MenaQ7, Vitamin K2 as MK-7

MenaQ7® is the first and only clinically validated and patented Vitamin K2 as MK-7 available on the market today. MK-7 is recognized in scientific literature for providing optimal activity and vitamin K status in the body, supporting bone and cardiovascular health, and MenaQ7® has demonstrated these strengths and benefits in human clinical trials.

 

Since MenaQ7® was first introduced, novel technologies have been pioneered to expand the product portfolio. Today, the MenaQ7® product range caters to a growing global demand of high-purity, stable, and well-researched Vitamin K2 as MK-7, and is offered as a naturally fermented ingredient (MenaQ7® Crystals) or a nature-identical synthetic ingredient (MenaQ7®PURE), in multiple dilutions and solubilities. All varieties are suitable for vegans and vegetarians, free from gluten, dairy, soy, and other known allergens.

MenaQ7® Vitamin K2 as Menaquinone-7 (MK-7) Facts:

  • Vitamin K2 as menaquinone-7 (MK-7) is the most bioavailable, longest-lasting, and most bioactive form of Vitamin K.
  • MenaQ7® is the ONLY vitamin K supplement effective within current RDIs, shown to be safe and effective at just 45 mcg daily.
  • MenaQ7® is the first and ONLY clinically supported, patented vitamin K2 on the market today.

Contact Us

Eric Anderson
Senior Vice President Global Sales & Marketing
eric.anderson@nattopharma.com

Collene Villalobos
Sales Manager, Americas
collene.villalobos@nattopharma.com

Rudi De Man
Vice President Sales Europe & Asia
rudi.deman@nattopharma.com

Gunilla Traberg
Director of Nordic Accounts & EU Marketing
gunilla.traberg@nattopharma.com

NattoPharma contact information:
Main office: Lilleakerveien 2B, 0283 Oslo,Norway
North American Subsidary: 328 Amboy Ave.,Ste. D,Metuchen, NJ 08840
Tel: (+47) 40 00 90 08
Tel: (+1) 609-454-2992
E-mail: info@nattopharma.com
E-mail: info.US@nattopharma.com
Created by:
Nutricon logo.
Search term:
Newsletter